Cellectar Biosciences, a Madison company working on cancer-fighting compounds, reported a net loss of $5.5 million, or $7.03 a share for the 2015 fiscal year, down from a net loss of $8.1 million, or $17.53 a share, for 2014. Read the full Wisconsin State Journal story here.
;
Hear from former winners of the #Wisconsin Governor's Business Plan Contest at our #Innovation Network Luncheon on 5/9 the @uwm's Innovation Accelerator in Wauwatosa!
Learn more and register: https://loom.ly/npKwq2Y #startup
Check out the latest #tech- and #entrepreneurial-related news, events and #jobopportunities in our newsletter! https://loom.ly/xG_9cJ0
.@gener8tor #Madison invests $600k in six startups. https://loom.ly/onW9GQQ #entrepreneur #startup
.@uwhealth: Clinical trial examines new way of eliminating kidney stones. https://loom.ly/kvnwoIU via @wisbusiness #clinicaltrials #clinicalresearch
Clinical trial examines new way of eliminating kidney stones. https://loom.ly/KWAtQT0 via @wisbusiness #clinicaltrials #clinialresearch
.@uwgb, @stnorbert #partnership lets #students study at both schools. via @wpr #education
UW-Green Bay, St. Norbert partnership lets students study at both schools
The University of Wisconsin-Green Bay and St. Norbert College are partnering to let students seamlessly study at both schools beginning this fall.
loom.ly